Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Wound
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 2
1 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of Pentadecapeptide BPC 157 for Accelerated Repair of Acute Grade II Hamstring Strain Confirmed by MRI
Hamstring Muscle Strain · Skeletal Muscle Injury
Enrolment: 120 · Results not recorded
Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02 (active ingredient BPC-157), a Pentadecapeptide From Gastric Source
Healthy Volunteers
Enrolment: 42 · Results not recorded
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatWoundWistarMaleIntravenous, intraperitoneal or intragastric10 ug/kg or 10 ng/kgImmediately after challenge
Model: Tail/limb amputation with heparin, warfarin or aspirin
BPC 157 reduced bleeding time and thrombocytopenia and prolonged survival after amputation in anticoagulant-treated rats.
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.
